Precipio, Inc. (PRPO)
NASDAQ: PRPO · Real-Time Price · USD
6.00
0.00 (0.00%)
Nov 20, 2024, 4:00 PM EST - Market closed
Precipio Revenue
Precipio had revenue of $5.21M in the quarter ending September 30, 2024, with 15.29% growth. This brings the company's revenue in the last twelve months to $17.41M, up 31.31% year-over-year. In the year 2023, Precipio had annual revenue of $15.20M with 61.46% growth.
Revenue (ttm)
$17.41M
Revenue Growth
+31.31%
P/S Ratio
0.50
Revenue / Employee
$305,456
Employees
57
Market Cap
8.89M
Revenue Chart
Revenue History
Sources: Historical revenue is based on company filings submitted to the U.S. Securities and Exchange Commission (SEC). The most recent revenue numbers may be taken from company press releases.
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
Company Name | Revenue |
---|---|
Aytu BioPharma | 79.76M |
Jaguar Health | 10.48M |
Evogene | 9.45M |
Ensysce Biosciences | 4.42M |
RedHill Biopharma | 3.71M |
BioRestorative Therapies | 377.00K |
Soligenix | 364.18K |
PRPO News
- 2 days ago - Precipio, Inc. (PRPO) Q3 2024 Earnings Call Transcript - Seeking Alpha
- 14 days ago - Precipio Announces Q3-2024 Shareholder Update Call - GlobeNewsWire
- 6 weeks ago - Precipio Expands Bloodhound™ MPN Panel by Adding CALR Mutation Subtyping - GlobeNewsWire
- 2 months ago - Precipio Announces Employee Stock Option Plan Repricing - GlobeNewsWire
- 3 months ago - Precipio, Inc. (PRPO) Q2 2024 Earnings Call Transcript - Seeking Alpha
- 3 months ago - Precipio Announces Q2-2024 Shareholder Update Call - GlobeNewsWire
- 4 months ago - Precipio Reports $0.3M cash generated by operations (unaudited) in Q2-2024, as the company advances towards breakeven - GlobeNewsWire
- 4 months ago - Precipio Reports $4.4M for Q2-2024 (unaudited) Revenues, a leap of 30% from Q1-2024 - GlobeNewsWire